HopeStage
Back to all studies
CompletedNCT01981759

D-Cycloserine Added to CBT for Delusions

About this titleRead the official source — NCT01981759
Medication studyAges 18–68United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 68 years.

Listed locations
Baltimore and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 2014
Recruitment status
Completed
Enrollment listed in the registry
58
Sponsor
NYU Langone Health
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Behavioural, Drug, Other
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 68 Years
Official registry ID
NCT01981759
Official title
Show the full official title

D-Cycloserine Augmentation of Cognitive Behavioral Therapy for Delusions

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Baltimore · New York

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is NYU Langone Health.

Did this study involve medication?

Yes. The study involved medication, including D-Cycloserine.

Who was this study for?

Listed age limits: 18 years to 68 years.

Want to explore more studies?

Explore studies